Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia
- PMID: 34582775
- PMCID: PMC10627379
- DOI: 10.1016/j.ahj.2021.09.008
Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia
Abstract
Background: The ISCHEMIA-CKD (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease) trial found no advantage to an invasive strategy compared to conservative management in reducing all-cause death or myocardial infarction (D/MI). However, the prognostic influence of angiographic coronary artery disease (CAD) burden and ischemia severity remains unknown in this population. We compared the relative impact of CAD extent and severity of myocardial ischemia on D/MI in patients with advanced chronic kidney disease (CKD).
Methods: Participants randomized to invasive management with available data on coronary angiography and stress testing were included. Extent of CAD was defined by the number of major epicardial vessels with ≥50% diameter stenosis by quantitative coronary angiography. Ischemia severity was assessed by site investigators as moderate or severe using trial definitions. The primary endpoint was D/MI.
Results: Of the 388 participants, 307 (79.1%) had complete coronary angiography and stress testing data. D/MI occurred in 104/307 participants (33.9%). Extent of CAD was associated with an increased risk of D/MI (P < .001), while ischemia severity was not (P = .249). These relationships persisted following multivariable adjustment. Using 0-vessel disease (VD) as reference, the adjusted hazard ratio (HR) for 1VD was 1.86, 95% confidence interval (CI) 0.94 to 3.68, P = .073; 2VD: HR 2.13, 95% CI 1.10 to 4.12, P = .025; 3VD: HR 4.00, 95% CI 2.06 to 7.76, P < .001. Using moderate ischemia as the reference, the HR for severe ischemia was 0.84, 95% CI 0.54 to 1.30, P = .427.
Conclusion: Among ISCHEMIA-CKD participants randomized to the invasive strategy, extent of CAD predicted D/MI whereas severity of ischemia did not.
Copyright © 2021 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.Circulation. 2021 Sep 28;144(13):1024-1038. doi: 10.1161/CIRCULATIONAHA.120.049755. Epub 2021 Sep 9. Circulation. 2021. PMID: 34496632 Free PMC article. Clinical Trial.
-
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.Circ Cardiovasc Interv. 2022 Aug;15(8):e012103. doi: 10.1161/CIRCINTERVENTIONS.122.012103. Epub 2022 Aug 16. Circ Cardiovasc Interv. 2022. PMID: 35973009 Free PMC article. Clinical Trial.
-
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.J Am Coll Cardiol. 2021 Jul 27;78(4):348-361. doi: 10.1016/j.jacc.2021.05.001. Epub 2021 May 11. J Am Coll Cardiol. 2021. PMID: 33989711 Free PMC article. Clinical Trial.
-
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.Am Heart J. 2018 Jul;201:124-135. doi: 10.1016/j.ahj.2018.04.011. Epub 2018 Apr 21. Am Heart J. 2018. PMID: 29778671 Free PMC article. Review.
-
Approach to stable angina in patients with advanced chronic kidney disease.Curr Opin Nephrol Hypertens. 2021 May 1;30(3):339-345. doi: 10.1097/MNH.0000000000000709. Curr Opin Nephrol Hypertens. 2021. PMID: 33767062 Review.
Cited by
-
Ischemia Trial: Does the Cardiology Community Need to Pivot or Continue Current Practices?Curr Cardiol Rep. 2022 Aug;24(8):1059-1068. doi: 10.1007/s11886-022-01725-1. Epub 2022 Jun 2. Curr Cardiol Rep. 2022. PMID: 35653055 Free PMC article. Review.
-
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.Circ Cardiovasc Interv. 2024 Dec;17(12):e013743. doi: 10.1161/CIRCINTERVENTIONS.123.013743. Epub 2024 Dec 17. Circ Cardiovasc Interv. 2024. PMID: 39689188 Clinical Trial.
References
-
- Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296–305. - PubMed
-
- Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet [Internet] 2012;380:807–14. [cited 2021 Mar 21]Available from https://pubmed.ncbi.nlm.nih.gov/22717317/. - PubMed
-
- Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol [Internet] 2006;17:2034–47. [cited 2021 Mar 7]Available from http://www.jasn.orgwww.jasn.org. - PubMed
-
- Collins AJ, Foley RN, Chavers B, et al. US renal data system 2011 Annual data report [Internet]. Am J Kidney Dis 2012;59:A7. [cited 2021 Mar 7]Available from https://linkinghub.elsevier.com/retrieve/pii/S027263861101571X. - PubMed
-
- Thompson S, James M, Wiebe N, et al. CLINICAL EPIDEMIOLOGY cause of death in patients with reduced kidney function. J Am Soc Nephrol [Internet] 2015;26:2504–11. [cited 2021 Mar 7]Available from http://www.jasn.orgwww.jasn.org. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous